首页 | 本学科首页   官方微博 | 高级检索  
检索        

新型糖原磷酸化酶抑制剂山楂酸对Ⅱ型糖尿病大鼠的神经保护作用
引用本文:关腾,钱贻崧,黄梦昊,黄龙飞,汤旭蓁,李运曼,孙宏斌.新型糖原磷酸化酶抑制剂山楂酸对Ⅱ型糖尿病大鼠的神经保护作用[J].中国天然药物,2010(4):293-297.
作者姓名:关腾  钱贻崧  黄梦昊  黄龙飞  汤旭蓁  李运曼  孙宏斌
作者单位:[1]中国药科大学生理教研室,南京210009 [2]中国药科大学新药研究中心,南京210009
基金项目:【基金项目】国家自然科学基金资助项目(No.30672523,90713037);教育部科技创新工程重大项目培育基金资助项目(No.706030,20050316008)
摘    要:目的:探讨新型糖原磷酸化酶抑制剂山楂酸(MA)对高血糖大鼠脑缺血/再灌损伤的作用。方法:通过高脂饮食(HFD)合并低剂量链脲佐菌素(STZ)注射,制作II型糖尿病大鼠模型。不同剂量MA(10,5和2.5mg·kg?1·d?1)灌胃2周。双侧颈总结扎诱导建立大鼠脑缺血模型,评价MA对脑缺血/再灌II型糖尿病大鼠神经保护作用。结果:MA可显著降低II型糖尿病大鼠的空腹血糖(GLU)、血浆甘油三酯(TG)和总胆固醇(TC)水平。脑缺血II型糖尿病大鼠脑组织中丙二醛(MDA)含量显著增高,超氧化物歧化酶(SOD)活性显著下降;缺血3d后海马CA1区可观察到显著神经元损伤。MA显著减轻脑缺血损伤,并呈剂量依赖性。此外,MA可显著降低皮层和海马区MDA含量,减轻脑组织的脂质过氧化反应,提高缺血再灌大鼠脑组织的SOD活性。结论:MA预作用对II型糖尿病合并脑缺血诱导的损伤具有良好的保护作用。

关 键 词:糖原磷酸化酶  山楂酸  神经保护  II型糖尿病

Neuroprotection of Maslinic Acid,a Novel Glycogen Phosphorylase Inhibitor,in Type 2 Diabetic Rats
GUAN Teng,QIAN Yi-Song,HUANG Meng-Hao,HUANG Long-Fei,TANG Xu-Zhen,LI Yun-Man,*,SUN Hong-Bin.Neuroprotection of Maslinic Acid,a Novel Glycogen Phosphorylase Inhibitor,in Type 2 Diabetic Rats[J].Chinese JOurnal of Natural Medicines,2010(4):293-297.
Authors:GUAN Teng  QIAN Yi-Song  HUANG Meng-Hao  HUANG Long-Fei  TANG Xu-Zhen  LI Yun-Man    SUN Hong-Bin
Institution:1Department of Physiology,China Pharmaceutical University,Nanjing 210009;2Center for Drug Discovery,China Pharmaceutical University,Nanjing 210009,China
Abstract:AIM:To investigate the effects of maslinic acid(MA),a novel glycogen phosphorylase inhibitor in hyperglycemic rats after cerebral ischemia/reperfusion injury.METHODS:Rats were fed with high fat diet(HFD) followed by low-dose streptozotocin(STZ) injection to induce metabolic syndrome.Three doses of MA(10,5 and 2.5 mg·kg?1·d?1) were administered once daily by i.g.for 2 weeks.Neurological outcomes were compared in vehicle and MA treated HFD/STZ rats with cerebral ischemia/reperfusion injury induced by bilateral common carotid artery occlusion.RESULTS:The elevation of plasma fasting glucose(GLU),serum plasma triglyceride(TG) and plasma total cholesterol(TC) was antagonized by MA significantly.Cerebral ischemia with pre-existing hyperglycemia and hyperlipemia caused prominent elevation in MDA levels and decrease in SOD activity.Extensive neuronal death occurred in the CA1 area of hippocampus at day 3 after forebrain ischemia.MA significantly attenuated ischemia-induced neuronal death in a dose-dependent manner.Moreover,MA caused a significant reduction in MDA levels and elevation in SOD activity in both cortex and hippocampus.CONCLUSION:Results suggested the prophylaxis of MA may also show beneficial effects in reducing cerebral damage after stroke for patients with type 2 diabetes.
Keywords:Glycogen Phosphorylase  Maslinic acid  Neuroprotection  Type 2 diabetes
本文献已被 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号